Yearly Publication Trends - mrna vaccines

Year	Publication Count
2024	757
2023	2453
2022	1903
2021	823
2020	78
2019	34
2018	10
2017	16
2016	20
2015	7
2014	9

Relevant Publications

Imprinting of IgA responses in previously infected individuals receiving bivalent mRNA vaccines (WT and BA.4/BA.5 or WT and BA.1).

Issue Release: 2024

COVID-19 vaccination and major cardiovascular and haematological adverse events in Abu Dhabi: retrospective cohort study.

Issue Release: 2024

mRNA vaccines against infectious diseases and future direction.

Issue Release: 2024

Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice.

Issue Release: 2024

Human Immunodeficiency Virus Vaccine: Promise and Challenges.

Issue Release: 2024

Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity.

Issue Release: 2024

How effective is the BNT162b2 mRNA vaccine against SARS-CoV-2 transmission and infection? A national programme analysis in Monaco, July 2021 to September 2022.

Issue Release: 2024

Comparable antibody levels in heterologous and homologous mRNA COVID-19 vaccination, with superior neutralizing and IgA antibody responses in mRNA homologous boosting.

Issue Release: 2024

Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model.

Issue Release: 2024

Safety concern of recombination between self-amplifying mRNA vaccines and viruses is mitigated in vivo.

Issue Release: 2024

Role of aptamer technology in extracellular vesicle biology and therapeutic applications.

Issue Release: 2024

Distinct dynamics of mRNA LNPs in mice and nonhuman primates revealed by in vivo imaging.

Issue Release: 2024

Risk of breakthrough infection and hospitalisation after COVID-19 primary vaccination by HIV status in four Italian regions during 2021.

Issue Release: 2024

Immune response against the SARS-CoV-2 spike protein in cancer patients after COVID-19 vaccination during the Omicron wave: a prospective study.

Issue Release: 2024

Alternaria Allergy and Immunotherapy.

Issue Release: 2024

Real-World Effectiveness and Safety of Tixagevimab-Cilgavimab: A Target Trial Emulation Study.

Issue Release: 2024

Myocarditis associated with COVID-19 vaccination.

Issue Release: 2024

Supercoiled DNA percentage: A key in-process control of linear DNA template for mRNA drug substance manufacturing.

Issue Release: 2024

COVID-19 Vaccination in Pregnancy: Pilot Study of Plasma MicroRNAs Associated with Inflammatory Cytokines after COVID-19 mRNA Vaccination.

Issue Release: 2024

Immuno-Microbial Signature of Vaccine-Induced Immunity against SARS-CoV-2.

Issue Release: 2024

How Does the Immune System Respond to a Vaccine?

When Should I Take Acetaminophen After Vaccination?

What is Plasmodium Falciparum?

What are Double-Blind Studies?

What is an Emergency Use Authorization (EUA)?

How are Clinical Trials Designed to Assess Efficacy?

What is Measles Surveillance?

How are Antigens Selected for Vaccines?

Are Booster Doses Necessary?

What is the Future of T Cell-Based Vaccines?

Partnered Content Networks

Relevant Topics